Media.quretech.com

Media.quretech.com has Server used 93.188.2.52 IP Address with Hostname in Sweden. Below listing website ranking, Similar Webs, Backlinks. This domain was first Unknown and hosted in Sweden, server ping response time 191 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Media keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Mediatakeout
2 Mediaite
3 Mediafire
4 Media matters
5 Media
6 Median
7 Mediatakeout.com
8 Media creation tool
9 Media player

Hosting Provider

Website: Media.quretech.com
Hostname: webfront2.webcluster.loopia.se
Country:
Latitude: 59.329399108887
Longitude: 18.068599700928
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Bookmarking-online.win (8 seconds ago)

   » Niagaraonthemap.org (5 seconds ago)

   » Androuet.com (2 seconds ago)

   » Msuenergy.com (21 seconds ago)

   » Paradigmsanfrancisco.com (7 seconds ago)

   » Saratogawalkingtours.com (12 seconds ago)

   » Gamisterbaru.net (1 seconds ago)

   » Medicalhair4u.com (37 seconds ago)

   » Thomastonhousing.org (1 seconds ago)

Results For Websites Listing

Found 39 Websites with content related to this domain, It is result after search with search engine

QURETECH BIO AB

(1 month ago) QURETECH BIO AB Defeats bacterial virulence without affecting the normal bacterial flora Market Need And Potential Antibiotic resistance is a serious and accelerating problem. Infections with multidrug resistant bacteria cause around 25 000 deaths annually in the EU alone, and the accompanying economic burden is immense. Without

http://media.quretech.com/2014/05/QTB-TUb-2016-final.pdf

DA: 18 PA: 31 MOZ Rank: 49

QureTech Bio secures US patent - Nordic Life Science – the

(5 day ago) QureTech Bio has received preliminary approval for a patent application in the US for a drug candidate that helps treat tuberculosis. “The US is a key market for us so this news really helps strengthen our position. We are at a very exciting stage right now,” says Fredrik Almqvist, CEO of QureTech Bio.

https://nordiclifescience.org/quretech-bio-secures-us-patent/

DA: 21 PA: 32 MOZ Rank: 53

First-line drugs to combat infectious diseases - Quretech Bio

(6 day ago) QureTech Bio’s vision is to develop first-line drugs to combat infectious diseases and the occurrence of antibiotic resistance. Quretech Bio was founded in 2010 to commercialize world-leading research from groups based at Umeå University, Sweden, and Washington University, St Louis, USA.

https://quretech.com/infectious-diseases/

DA: 12 PA: 21 MOZ Rank: 33

QureTech Bio awarded 3 million SEK - Nordic Life Science

(1 month ago) QureTech Bio has received a SEK 3 million grant from the Swelife innovation programme, funded by the Swedish Government via Vinnova. “We are delighted to receive this grant, as it will enable us to create a product that can help patients and save lives,” says Fredrik Almqvist, CEO of QureTech Bio.

https://nordiclifescience.org/quretech-bio-awarded-3-million-sek/

DA: 21 PA: 36 MOZ Rank: 57

Quretech Bio - fighting bacterial virulence - UBI

(2 month ago) Quretech Bio develops innovative antibiotics by stopping bacterial virulence with a first-in-class active substance. The approach is not to kill bacteria, but make them harmless – thus complementing existing treatments and making established antibiotic drugs more effective without causing resistance.

https://www.ubi.se/case/quretech-bio-fighting-bacterial-virulence/

DA: 10 PA: 48 MOZ Rank: 58

QureTech Bio granted millions to fight antibiotic

(2 month ago) Quretech Bio Co-Founder and CEO [email protected] +46 70-397 90 97. About Quretech Bio: Quretech Bio is a Swedish pharmaceutical development company that addresses a significant medical need by developing a new class of antibacterial agents that target antimicrobial resistance.

https://www.ubi.se/news/quretech-bio-granted-millions-to-fight-antibiotic-resistance/

DA: 10 PA: 50 MOZ Rank: 77

Researchers from Quretech Bio AB awarded additional

(2 month ago) Researchers from Quretech Bio AB (Quretech Bio) in Umeå, who were awarded a research grant of approximately SEK 25 million in the summer, have been awarded additional funding of just over SEK 17 million this autumn (made up of SEK 7.5 million from the Swedish Research Council, SEK 8 million from the Erling Persson Family Foundation and SEK 2.1 million from Umeå University).

https://www.ubi.se/news/forskarna-bakom-quretech-bio-erhaller-ytterligare-17-msek-i-anslag/

DA: 10 PA: 50 MOZ Rank: 83

Quretech Bio takes its first external investor - Nordic

(1 month ago) “Quretech Bio has several interesting projects in its portfolio with real potential in infectious treatment, one of today’s biggest challenges. Together with the company’s extremely competent employees, we now have a very interesting trip in front of us, where we seriously believe that the company can make a difference,“ he says Håkan.

https://nordiclifescience.org/quretech-bio-takes-its-first-external-investor/

DA: 21 PA: 48 MOZ Rank: 69

QureTech Bio has secured a US patent for tuberculosis

(1 month ago) Umeå-based QureTech Bio has received preliminary approval for a patent application in the US for a drug candidate that helps treat tuberculosis. “The US is a key market for us so this news

http://www.mynewsdesk.com/se/umeaa-biotech-incubator/pressreleases/quretech-bio-has-secured-a-us-patent-for-tuberculosis-treatment-3014699

DA: 18 PA: 50 MOZ Rank: 50

Unparallelled hat trick by UBI startups - three awards in

(2 month ago) Quretech, Hiloprobe and Inficure made the 30th of March a day to remember for Umeå Biotech Incubator. Beeing at three different events, in three parts of Sweden - they all managed to take home the main prize. An unprecedented hat trick that shows how strong the startup portfolio from Umeå really is.

https://www.ubi.se/news/quretech-hiloprobe-inficure-take-home-first-prize-competitions-three-different-locations-one-day/

DA: 10 PA: 50 MOZ Rank: 50

Recently Analyzed Sites